NEW YORK (GenomeWeb) – Illumina today announced an alliance with Germany's Merck KGaA and Australian fertility firm Genea to improve fertility-related technologies and laboratory processes.

The alliance will work to standardize assisted reproductive treatment (ART) laboratory processes. "This will ensure a consistently high level of performance between different centers and countries," Merck KGaA Head of Global Strategy and Franchises Meeta Gulyani said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.